| pubmed-article:16278397 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16278397 | lifeskim:mentions | umls-concept:C0033325 | lld:lifeskim |
| pubmed-article:16278397 | lifeskim:mentions | umls-concept:C0032854 | lld:lifeskim |
| pubmed-article:16278397 | lifeskim:mentions | umls-concept:C0023434 | lld:lifeskim |
| pubmed-article:16278397 | lifeskim:mentions | umls-concept:C0332835 | lld:lifeskim |
| pubmed-article:16278397 | lifeskim:mentions | umls-concept:C0008625 | lld:lifeskim |
| pubmed-article:16278397 | lifeskim:mentions | umls-concept:C0017337 | lld:lifeskim |
| pubmed-article:16278397 | lifeskim:mentions | umls-concept:C0021027 | lld:lifeskim |
| pubmed-article:16278397 | lifeskim:mentions | umls-concept:C0009647 | lld:lifeskim |
| pubmed-article:16278397 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
| pubmed-article:16278397 | lifeskim:mentions | umls-concept:C0040808 | lld:lifeskim |
| pubmed-article:16278397 | lifeskim:mentions | umls-concept:C1561558 | lld:lifeskim |
| pubmed-article:16278397 | lifeskim:mentions | umls-concept:C0439828 | lld:lifeskim |
| pubmed-article:16278397 | lifeskim:mentions | umls-concept:C1515895 | lld:lifeskim |
| pubmed-article:16278397 | lifeskim:mentions | umls-concept:C0522510 | lld:lifeskim |
| pubmed-article:16278397 | pubmed:issue | 21 | lld:pubmed |
| pubmed-article:16278397 | pubmed:dateCreated | 2005-11-9 | lld:pubmed |
| pubmed-article:16278397 | pubmed:abstractText | To evaluate the efficacy of reduced intensity conditioning (RIC) allogeneic transplant in 30 patients with poor-prognosis chronic lymphocytic leukemia (CLL) and/or high-risk molecular/cytogenetic characteristics. | lld:pubmed |
| pubmed-article:16278397 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16278397 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16278397 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16278397 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16278397 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16278397 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16278397 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16278397 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16278397 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16278397 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:16278397 | pubmed:issn | 1078-0432 | lld:pubmed |
| pubmed-article:16278397 | pubmed:author | pubmed-author:MartinoRodrig... | lld:pubmed |
| pubmed-article:16278397 | pubmed:author | pubmed-author:CaballeroDolo... | lld:pubmed |
| pubmed-article:16278397 | pubmed:author | pubmed-author:de la... | lld:pubmed |
| pubmed-article:16278397 | pubmed:author | pubmed-author:CabreraRafael... | lld:pubmed |
| pubmed-article:16278397 | pubmed:author | pubmed-author:LeónAngelA | lld:pubmed |
| pubmed-article:16278397 | pubmed:author | pubmed-author:GonzálezMarco... | lld:pubmed |
| pubmed-article:16278397 | pubmed:author | pubmed-author:SierraJorgeJ | lld:pubmed |
| pubmed-article:16278397 | pubmed:author | pubmed-author:San... | lld:pubmed |
| pubmed-article:16278397 | pubmed:author | pubmed-author:SanzGuillermo... | lld:pubmed |
| pubmed-article:16278397 | pubmed:author | pubmed-author:RiberaJosé... | lld:pubmed |
| pubmed-article:16278397 | pubmed:author | pubmed-author:García-MarcoJ... | lld:pubmed |
| pubmed-article:16278397 | pubmed:author | pubmed-author:MateosVictori... | lld:pubmed |
| pubmed-article:16278397 | pubmed:author | pubmed-author:SarráJoséJ | lld:pubmed |
| pubmed-article:16278397 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16278397 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:16278397 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:16278397 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16278397 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16278397 | pubmed:pagination | 7757-63 | lld:pubmed |
| pubmed-article:16278397 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:meshHeading | pubmed-meshheading:16278397... | lld:pubmed |
| pubmed-article:16278397 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16278397 | pubmed:articleTitle | Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-). | lld:pubmed |
| pubmed-article:16278397 | pubmed:affiliation | Hospital Clínico Universitario de Salamanca, Spain. cabarri@usal.es | lld:pubmed |
| pubmed-article:16278397 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16278397 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16278397 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16278397 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16278397 | lld:pubmed |
